ArticleMolecular therapy. Methods & clinical development2023

CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy.

Harry Wilton-Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.